Clinical Trial Update: The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial investigating gut recolonization by fecal transplantation for recurrent Clostridioides difficile infection completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Difficile Diarrhea

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Clostridium Difficile Infection, C.Difficile Diarrhea | Phase 2 | Status: COMPLETED | Results posted: 2021-03-15